Literature DB >> 8395705

Synthesis and degradation of cyclic ADP-ribose by NAD glycohydrolases.

H Kim1, E L Jacobson, M K Jacobson.   

Abstract

Cyclic adenosine diphosphoribose (cADPR), a recently discovered metabolite of nicotinamide adenine dinucleotide (NAD), is a potent calcium-releasing agent postulated to be a new second messenger. An enzyme that catalyzes the synthesis of cADPR from NAD and the hydrolysis of cADPR to ADP-ribose (ADPR) was purified to homogeneity from canine spleen microsomes. The net conversion of NAD to ADPR categorizes this enzyme as an NAD glycohydrolase. NAD glycohydrolases are ubiquitous membrane-bound enzymes that have been known for many years but whose function has not been identified. The results presented here suggest that these enzymes may function in the regulation of calcium homeostasis by the ability to synthesize and degrade cADPR.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8395705     DOI: 10.1126/science.8395705

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  60 in total

1.  Kinetic competence of the cADP-ribose-CD38 complex as an intermediate in the CD38/NAD+ glycohydrolase-catalysed reactions: implication for CD38 signalling.

Authors:  C Cakir-Kiefer; H Muller-Steffner; N Oppenheimer; F Schuber
Journal:  Biochem J       Date:  2001-09-01       Impact factor: 3.857

2.  Cellular effects and metabolic stability of N1-cyclic inosine diphosphoribose and its derivatives.

Authors:  T Kirchberger; G Wagner; J Xu; C Cordiglieri; P Wang; A Gasser; R Fliegert; S Bruhn; A Flügel; F E Lund; L-H Zhang; B V L Potter; A H Guse
Journal:  Br J Pharmacol       Date:  2006-09-11       Impact factor: 8.739

3.  Structure and enzymatic functions of human CD38.

Authors:  Hon Cheung Lee
Journal:  Mol Med       Date:  2006 Nov-Dec       Impact factor: 6.354

4.  Channelling of substrate promiscuity of the skeletal-muscle ADP-ribosyl cyclase isoform.

Authors:  Ingrid Bacher; Andreas Zidar; Martin Kratzel; Martin Hohenegger
Journal:  Biochem J       Date:  2004-07-01       Impact factor: 3.857

5.  The NAD+ synthesizing enzyme nicotinamide mononucleotide adenylyltransferase 2 (NMNAT-2) is a p53 downstream target.

Authors:  Lu-Zhe Pan; Dae-Gyun Ahn; Tanveer Sharif; Derek Clements; Shashi A Gujar; Patrick W K Lee
Journal:  Cell Cycle       Date:  2014-02-07       Impact factor: 4.534

Review 6.  CD38 as a regulator of cellular NAD: a novel potential pharmacological target for metabolic conditions.

Authors:  Eduardo Nunes Chini
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

7.  Secretion of quinolinic acid, an intermediate in the kynurenine pathway, for utilization in NAD+ biosynthesis in the yeast Saccharomyces cerevisiae.

Authors:  Kazuto Ohashi; Shigeyuki Kawai; Kousaku Murata
Journal:  Eukaryot Cell       Date:  2013-03-01

8.  CD38 expression as response of hematopoietic system to cancer.

Authors:  Işil Albeniz; Ozlem Demir-Coşkun; Leyla Türker-Şener; Aycan Baş; Oktar Asoğlu; Rüstem Nurten
Journal:  Oncol Lett       Date:  2011-05-16       Impact factor: 2.967

9.  Inhibition of the intrinsic NAD+ glycohydrolase activity of CD38 by carbocyclic NAD analogues.

Authors:  K A Wall; M Klis; J Kornet; D Coyle; J C Amé; M K Jacobson; J T Slama
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

10.  Rat liver mitochondrial ADP-ribose pyrophosphatase in the matrix space with low Km for free ADP-ribose.

Authors:  D Bernet; R M Pinto; M J Costas; J Canales; J C Cameselle
Journal:  Biochem J       Date:  1994-05-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.